Clinical Development

Parexel sets its sights on stroke

Parexel sets its sights on stroke

By Phil Taylor

Parexel has made a bold foray into the troublesome arena of stroke drug development via an alliance with Safe Implementation of Treatments in Stroke (SITS) International, an international network of clinical sites geared up to recruit stroke patients.

Tough times continue at PharmaNet

Tough times continue at PharmaNet

By Phil Taylor

Clinical research specialist PharmaNet Development Group reported a decline in both sales and earnings for the third quarter but has kept its guidance for the financial year at the same level, albeit excluding an as-yet unresolved impairment charge.